Esteban Rivera

Jan 13, 2025 | blogs.fangraphs.com | Esteban Rivera

Lately, I’ve been very interested in analyzing hitters who make a living off crushing everything in the upper third of the strike zone. As the rise of four-seamers up in the zone has turned that area into a hole for more hitters (especially in terms of whiffs), having someone in the lineup who excels in that area is very valuable.

Jan 3, 2025 | blogs.fangraphs.com | Esteban Rivera

After last year’s disappointing follow-up to their 2023 World Series-winning season, the Texas Rangers jumped the first base market in December and improved the rest of their roster in the process.

Dec 6, 2024 | blogs.fangraphs.com | Esteban Rivera

I’ve been a fan of Brent Rooker since he was crushing baseballs at Mississippi State, so it was exciting to see him elevate his offense in 2023 after three years of struggling in the majors. His improvements stemmed from changes he made to his load. He added larger, slower movements as he prepared to swing, which helped him to generate more power while keeping his body under control.

Dec 3, 2024 | jheor.org | Anne Sydor |Esteban Rivera |Robert Popovian

INTRODUCTION As with any complex U.S. federal legislation, the Inflation Reduction Act (IRA), signed into law on August 16, 2022, includes provisions with positive and negative consequences for diverse stakeholders.1 Specific clauses affect health insurance premiums, patients’ out-of-pocket costs, and wholesale medication prices that will impact patients, biopharmaceutical companies, the insurance industry, and policymakers differently, depending on their perspectives and roles within the...

Dec 3, 2024 | jheor.org | Anne Sydor |Esteban Rivera |Robert Popovian

INTRODUCTION As with any complex U.S. federal legislation, the Inflation Reduction Act (IRA), signed into law on August 16, 2022, includes provisions with positive and negative consequences for diverse stakeholders.1 Specific clauses affect health insurance premiums, patients’ out-of-pocket costs, and wholesale medication prices that will impact patients, biopharmaceutical companies, the insurance industry, and policymakers differently, depending on their perspectives and roles within the...